Predictive Models for HCC Prognosis, Recurrence Risk, and Immune Infiltration Based on Two Exosomal Genes: MYL6B and THOC2-Reference-Cited by-同舟云学术

Predictive Models for HCC Prognosis, Recurrence Risk, and Immune Infiltration Based on Two Exosomal Genes: MYL6B and THOC2

Published:2021-08 Issue: Volume:Volume 14 Page:4089-4109
ISSN:1178-7031
Container-title:Journal of Inflammation Research
language:en
Short-container-title:JIR

Author:

Zhu Jinyu,Tang Bufu,Gao Yang,Xu Suqin,Tu Jianfei,Wang Yajie,Yang Weibin,Fang Shiji,Weng Qiaoyou^ORCID,Zhao Zhongwei,Xu Min,Yang Yang,Chen Minjiang,Lu Chenying,Ji Jiansong^ORCID

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Reference57 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. European Association for the Study of the Liver. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56(4):908–943.

3. Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma

4. Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer

5. Molecular signature of hepatocellular carcinoma, hope or hype in prognosis and therapy

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study on the expression and prognostic relationship of MYL6B in liver cancer based on bioinformatics;World Journal of Clinical Oncology;2024-09-24

2. Unleashing the potential of gene signatures as prognostic and predictive tools: A step closer to personalized medicine in hepatocellular carcinoma (HCC);Cell Biochemistry and Function;2024-01

3. TACE responser NDRG1 acts as a guardian against ferroptosis to drive tumorgenesis and metastasis in HCC;Biological Procedures Online;2023-05-19

4. Detection of sFas, sCD137, and IL-27 Cytokines as Potential Biomarkers for Hepatocellular Carcinoma Diagnosis;Journal of Hepatocellular Carcinoma;2023-05

5. Machine learning-based construction of a ferroptosis and necroptosis associated lncRNA signature for predicting prognosis and immunotherapy response in hepatocellular cancer;Frontiers in Oncology;2023-04-20